Alain Fournier - Publications

INRS-Institut Armand-Frappier, Laval 

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Alonso Martinez LM, Harel F, Létourneau M, Finnerty V, Fournier A, Dupuis J, DaSilva JN. SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases. American Journal of Nuclear Medicine and Molecular Imaging. 9: 203-215. PMID 31772819  0.32
2019 de Molliens MP, Jamadagni P, Létourneau M, Devost D, Hébert TE, Patten SA, Fournier A, Chatenet D. Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor. Biochimica Et Biophysica Acta. General Subjects. PMID 31306709 DOI: 10.1016/J.Bbagen.2019.07.007  0.32
2018 Alonso Martinez LM, Harel F, Nguyen QT, Létourneau M, D'Oliviera-Sousa C, Meloche B, Finnerty V, Fournier A, Dupuis J, DaSilva JN. AlF-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation. Nuclear Medicine and Biology. 67: 36-42. PMID 30388434 DOI: 10.1016/J.Nucmedbio.2018.10.003  0.32
2018 de Molliens MP, Létourneau M, Devost D, Hébert TE, Fournier A, Chatenet D. New insights about the peculiar role of the 28-38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection. Biochemical Pharmacology. PMID 29704474 DOI: 10.1016/J.Bcp.2018.04.024  0.32
2017 Tadevosyan A, Xiao J, Surinkaew S, Naud P, Merlen C, Harada M, Qi X, Chatenet D, Fournier A, Allen BG, Nattel S. Intracellular Angiotensin-II Interacts With Nuclear Angiotensin Receptors in Cardiac Fibroblasts and Regulates RNA Synthesis, Cell Proliferation, and Collagen Secretion. Journal of the American Heart Association. 6. PMID 28381466 DOI: 10.1161/Jaha.116.004965  0.32
2016 Therrien A, Fournier A, Lafleur M. Role of the Cationic C-Terminal Segment of Melittin on Membrane Fragmentation. The Journal of Physical Chemistry. B. PMID 27054924 DOI: 10.1021/Acs.Jpcb.5B11705  0.32
2016 Lamine-Ajili A, Fahmy AM, Létourneau M, Chatenet D, Labonté P, Vaudry D, Fournier A. Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease. Biochimica Et Biophysica Acta. 1862: 688-95. PMID 26769362 DOI: 10.1016/J.Bbadis.2016.01.005  0.32
2015 Harel F, Levac X, Nguyen QT, Létourneau M, Marcil S, Finnerty V, Cossette M, Fournier A, Dupuis J. Molecular Imaging of the Human Pulmonary Vascular Endothelium Using an Adrenomedullin Receptor Ligand. Molecular Imaging. 14: 7290201500003. PMID 28654347 DOI: 10.2310/7290.2015.00003  0.32
2015 Doan ND, Poujol de Molliens M, Létourneau M, Fournier A, Chatenet D. Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure-activity relationship study of a class B GPCR ligand. European Journal of Medicinal Chemistry. 104: 106-14. PMID 26448038 DOI: 10.1016/J.Ejmech.2015.09.017  0.32
2015 Tadevosyan A, Villeneuve LR, Fournier A, Chatenet D, Nattel S, Allen BG. Caged ligands to study the role of intracellular GPCRs. Methods (San Diego, Calif.). PMID 26196333 DOI: 10.1016/J.Ymeth.2015.07.005  0.32
2015 Lamine A, Létourneau M, Doan ND, Maucotel J, Couvineau A, Vaudry H, Chatenet D, Vaudry D, Fournier A. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model. Neuropharmacology. PMID 26006268 DOI: 10.1016/J.Neuropharm.2015.05.014  0.32
2015 Harel F, Levac X, Nguyen QT, Létourneau M, Marcil S, Finnerty V, Cossette M, Fournier A, Dupuis J. Molecular imaging of the human pulmonary vascular endothelium using an adrenomedullin receptor ligand. Molecular Imaging. 14. PMID 25812438 DOI: 10.2310/7290.2015.00003  0.32
2015 Vaudry H, Leprince J, Chatenet D, Fournier A, Lambert DG, Le Mével JC, Ohlstein EH, Schwertani A, Tostivint H, Vaudry D. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function. Pharmacological Reviews. 67: 214-58. PMID 25535277 DOI: 10.1124/Pr.114.009480  0.32
2015 Tadevosyan A, Létourneau M, Folch B, Doucet N, Villeneuve LR, Mamarbachi AM, Pétrin D, Hébert TE, Fournier A, Chatenet D, Allen BG, Nattel S. Photoreleasable ligands to study intracrine angiotensin II signalling. The Journal of Physiology. 593: 521-39. PMID 25433071 DOI: 10.1113/Jphysiol.2014.279109  0.32
2015 Chatenet D, Bourgault S, Fournier A. Design and application of light-activated probes for cellular signaling. Methods in Molecular Biology (Clifton, N.J.). 1234: 17-30. PMID 25304345 DOI: 10.1007/978-1-4939-1755-6_3  0.32
2014 Tchoumi Neree A, Nguyen PT, Chatenet D, Fournier A, Bourgault S. Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP. Febs Letters. 588: 4590-6. PMID 25447531 DOI: 10.1016/J.Febslet.2014.10.029  0.32
2014 Seaborn T, Ravni A, Au R, Chow BK, Fournier A, Wurtz O, Vaudry H, Eiden LE, Vaudry D. Induction of serpinb1a by PACAP or NGF is required for PC12 cells survival after serum withdrawal. Journal of Neurochemistry. 131: 21-32. PMID 24899316 DOI: 10.1111/Jnc.12780  0.32
2014 Jolivel V, Arthaud S, Botia B, Portal C, Delest B, Clavé G, Leprince J, Romieu A, Renard PY, Touzani O, Ligeret H, Noack P, Massonneau M, Fournier A, Vaudry H, et al. Biochemical characterization of a Caspase-3 far-red fluorescent probe for non-invasive optical imaging of neuronal apoptosis. Journal of Molecular Neuroscience : Mn. 54: 451-62. PMID 24865411 DOI: 10.1007/S12031-014-0325-4  0.32
2014 Raoult E, Bénard M, Komuro H, Lebon A, Vivien D, Fournier A, Vaudry H, Vaudry D, Galas L. Cortical-layer-specific effects of PACAP and tPA on interneuron migration during post-natal development of the cerebellum. Journal of Neurochemistry. 130: 241-54. PMID 24646324 DOI: 10.1111/Jnc.12714  0.32
2014 Nguyen TT, Folch B, Létourneau M, Truong NH, Doucet N, Fournier A, Chatenet D. Design of a truncated cardiotoxin-I analogue with potent insulinotropic activity. Journal of Medicinal Chemistry. 57: 2623-33. PMID 24552570 DOI: 10.1021/Jm401904Q  0.32
2013 Chatenet D, Folch B, Feytens D, Létourneau M, Tourwé D, Doucet N, Fournier A. Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists. Journal of Medicinal Chemistry. 56: 9612-22. PMID 24251366 DOI: 10.1021/Jm401153J  0.32
2013 Létourneau M, Nguyen QT, Harel F, Fournier A, Dupuis J. PulmoBind, an adrenomedullin-based molecular lung imaging tool. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1789-96. PMID 23949911 DOI: 10.2967/Jnumed.112.118984  0.32
2013 Merlen C, Farhat N, Luo X, Chatenet D, Tadevosyan A, Villeneuve LR, Gillis MA, Nattel S, Thorin E, Fournier A, Allen BG. Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes. Journal of Molecular and Cellular Cardiology. 62: 189-202. PMID 23756157 DOI: 10.1016/J.Yjmcc.2013.05.021  0.32
2013 Vaniotis G, Glazkova I, Merlen C, Smith C, Villeneuve LR, Chatenet D, Therien M, Fournier A, Tadevosyan A, Trieu P, Nattel S, Hébert TE, Allen BG. Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors. Journal of Molecular and Cellular Cardiology. 62: 58-68. PMID 23684854 DOI: 10.1016/J.Yjmcc.2013.05.003  0.32
2013 Basille-Dugay M, Vaudry H, Fournier A, Gonzalez B, Vaudry D. Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels. Frontiers in Endocrinology. 4: 56. PMID 23675369 DOI: 10.3389/Fendo.2013.00056  0.32
2013 Bureau A, Chagnon YC, Croteau J, Fournier A, Roy MA, Paccalet T, Mérette C, Maziade M. Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples. Biological Psychiatry. 74: 444-50. PMID 23602252 DOI: 10.1016/j.biopsych.2013.03.004  0.32
2013 Vaudry D, Burel D, Galas L, Lacaille H, Duterte-Boucher D, Chatenet D, Fournier A, Vaudry H. PACAP Handbook of Biologically Active Peptides. 1038-1043. DOI: 10.1016/B978-0-12-385095-9.00138-X  0.32
2012 Chatenet D, Nguyen TT, Létourneau M, Fournier A. Update on the urotensinergic system: new trends in receptor localization, activation, and drug design. Frontiers in Endocrinology. 3: 174. PMID 23293631 DOI: 10.3389/Fendo.2012.00174  0.32
2012 Doan ND, Létourneau M, Vaudry D, Doucet N, Folch B, Vaudry H, Fournier A, Chatenet D. Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 256-65. PMID 22922050 DOI: 10.1016/J.Jconrel.2012.08.021  0.32
2012 Nguyen TT, Folch B, Létourneau M, Vaudry D, Truong NH, Doucet N, Chatenet D, Fournier A. Cardiotoxin-I: an unexpectedly potent insulinotropic agent. Chembiochem : a European Journal of Chemical Biology. 13: 1805-12. PMID 22807058 DOI: 10.1002/Cbic.201200081  0.32
2012 Doan ND, Chatenet D, Létourneau M, Vaudry H, Vaudry D, Fournier A. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochimica Et Biophysica Acta. 1823: 940-9. PMID 22343001 DOI: 10.1016/J.Bbamcr.2012.02.001  0.32
2012 Nguyen TT, Létourneau M, Chatenet D, Fournier A. Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulation. The International Journal of Biochemistry & Cell Biology. 44: 639-47. PMID 22245063 DOI: 10.1016/J.Biocel.2011.12.022  0.32
2012 Chatenet D, Nguyen QT, Létourneau M, Dupuis J, Fournier A. Urocontrin, a novel UT receptor ligand with a unique pharmacological profile. Biochemical Pharmacology. 83: 608-15. PMID 22197588 DOI: 10.1016/J.Bcp.2011.12.009  0.32
2012 Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology. 62: 200-8. PMID 21803058 DOI: 10.1016/J.Neuropharm.2011.06.030  0.32
2011 El Kebir D, Zhang Y, Potempa LA, Wu Y, Fournier A, Filep JG. C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32. Journal of Leukocyte Biology. 90: 1167-75. PMID 21934067 DOI: 10.1189/Jlb.0111032  0.32
2011 Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP. Journal of Neurochemistry. 119: 920-31. PMID 21919910 DOI: 10.1111/J.1471-4159.2011.07486.X  0.32
2011 Fu Y, Létourneau M, Chatenet D, Dupuis J, Fournier A. Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine. Nuclear Medicine and Biology. 38: 867-74. PMID 21843783 DOI: 10.1016/J.Nucmedbio.2011.01.011  0.32
2011 Bourgault S, Chatenet D, Wurtz O, Doan ND, Leprince J, Vaudry H, Fournier A, Vaudry D. Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Current Pharmaceutical Design. 17: 1002-24. PMID 21524253 DOI: 10.2174/138161211795589337  0.32
2011 Dejda A, Seaborn T, Bourgault S, Touzani O, Fournier A, Vaudry H, Vaudry D. PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action. Peptides. 32: 1207-16. PMID 21514338 DOI: 10.1016/J.Peptides.2011.04.003  0.32
2011 Dejda A, Bourgault S, Doan ND, Létourneau M, Couvineau A, Vaudry H, Vaudry D, Fournier A. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP. Biochimie. 93: 669-77. PMID 21185349 DOI: 10.1016/J.Biochi.2010.12.010  0.32
2011 Doan ND, Bourgault S, Dejda A, Létourneau M, Detheux M, Vaudry D, Vaudry H, Chatenet D, Fournier A. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochemical Pharmacology. 81: 552-61. PMID 21114961 DOI: 10.1016/J.Bcp.2010.11.015  0.32
2010 Vaudry H, Do Rego JC, Le Mevel JC, Chatenet D, Tostivint H, Fournier A, Tonon MC, Pelletier G, Conlon JM, Leprince J. Urotensin II, from fish to human. Annals of the New York Academy of Sciences. 1200: 53-66. PMID 20633133 DOI: 10.1111/J.1749-6632.2010.05514.X  0.32
2009 Bourgault S, Vaudry D, Dejda A, Doan ND, Vaudry H, Fournier A. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Current Medicinal Chemistry. 16: 4462-80. PMID 19835562 DOI: 10.2174/092986709789712899  0.32
2009 Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacological Reviews. 61: 283-357. PMID 19805477 DOI: 10.1124/Pr.109.001370  0.32
2009 Fu Y, Létourneau M, Nguyen QT, Chatenet D, Dupuis J, Fournier A. Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging. European Journal of Pharmacology. 617: 118-23. PMID 19559019 DOI: 10.1016/J.Ejphar.2009.06.031  0.32
2009 Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 424-35. PMID 18536705 DOI: 10.1038/Npp.2008.73  0.32
2008 Dejda A, Jolivel V, Bourgault S, Seaborn T, Fournier A, Vaudry H, Vaudry D. Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. Journal of Molecular Neuroscience : Mn. 36: 26-37. PMID 18506634 DOI: 10.1007/S12031-008-9087-1  0.32
2008 Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H, Fournier A. Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides. 29: 919-32. PMID 18353507 DOI: 10.1016/J.Peptides.2008.01.022  0.32
2008 Doan ND, Bourgault S, Létourneau M, Fournier A. Effectiveness of the suzuki-miyaura cross-coupling reaction for solid-phase peptide modification. Journal of Combinatorial Chemistry. 10: 44-51. PMID 18067269 DOI: 10.1021/Cc700128B  0.32
2008 Parat M, McNicoll N, Wilkes B, Fournier A, De Léan A. Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A. Molecular Pharmacology. 73: 431-40. PMID 17965196 DOI: 10.1124/Mol.107.039982  0.32
2008 Leprince J, Chatenet D, Dubessy C, Fournier A, Pfeiffer B, Scalbert E, Renard P, Pacaud P, Oulyadi H, Ségalas-Milazzo I, Guilhaudis L, Davoust D, Tonon MC, Vaudry H. Structure-activity relationships of urotensin II and URP. Peptides. 29: 658-73. PMID 17931747 DOI: 10.1016/J.Peptides.2007.08.014  0.32
2007 Botia B, Basille M, Allais A, Raoult E, Falluel-Morel A, Galas L, Jolivel V, Wurtz O, Komuro H, Fournier A, Vaudry H, Burel D, Gonzalez BJ, Vaudry D. Neurotrophic effects of PACAP in the cerebellar cortex. Peptides. 28: 1746-52. PMID 17544170 DOI: 10.1016/J.Peptides.2007.04.013  0.32
2007 Viau M, Létourneau M, Sirois-Deslongchamps A, Boulanger Y, Fournier A. Study of solid-phase synthesis and purification strategies for the preparation of polyglutamine peptides. Biopolymers. 88: 754-63. PMID 17516502 DOI: 10.1002/Bip.20763  0.32
2007 Falluel-Morel A, Chafai M, Vaudry D, Basille M, Cazillis M, Aubert N, Louiset E, de Jouffrey S, Le Bigot JF, Fournier A, Gressens P, Rostène W, Vaudry H, Gonzalez BJ. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. Journal of Neuroendocrinology. 19: 321-7. PMID 17425606 DOI: 10.1111/J.1365-2826.2007.01537.X  0.32
2007 de Montgolfier B, Dufresne J, Letourneau M, Nagler JJ, Fournier A, Audet C, Cyr DG. The expression of multiple connexins throughout spermatogenesis in the rainbow trout testis suggests a role for complex intercellular communication. Biology of Reproduction. 76: 2-8. PMID 16971556 DOI: 10.1095/Biolreprod.106.054288  0.32
2006 Basille M, Falluel-Morel A, Vaudry D, Aubert N, Fournier A, Fréger P, Gallo-Payet N, Vaudry H, Gonzalez B. Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications. Regulatory Peptides. 137: 27-33. PMID 16963135 DOI: 10.1016/J.Regpep.2006.03.010  0.32
2006 Guillemot J, Aït-Ali D, Turquier V, Montero-Hadjadje M, Fournier A, Vaudry H, Anouar Y, Yon L. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells. Regulatory Peptides. 137: 79-88. PMID 16963134 DOI: 10.1016/J.Regpep.2006.04.023  0.32
2006 Guillemot J, Ait-Ali D, Turquier V, Montero-Hadjadje M, Fournier A, Vaudry H, Anouar Y, Yon L. PACAP stimulates the release of the secretogranin II-derived peptide EM66 from chromaffin cells. Annals of the New York Academy of Sciences. 1070: 309-12. PMID 16888183 DOI: 10.1196/Annals.1317.033  0.32
2006 Falluel-Morel A, Vaudry D, Aubert N, Galas L, Benard M, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. PACAP and ceramides exert opposite effects on migration, neurite outgrowth, and cytoskeleton remodeling. Annals of the New York Academy of Sciences. 1070: 265-70. PMID 16888176 DOI: 10.1196/Annals.1317.024  0.32
2006 Ravni A, Bourgault S, Lebon A, Chan P, Galas L, Fournier A, Vaudry H, Gonzalez B, Eiden LE, Vaudry D. The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. Journal of Neurochemistry. 98: 321-9. PMID 16805827 DOI: 10.1111/J.1471-4159.2006.03884.X  0.32
2006 Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development. The Journal of Comparative Neurology. 496: 468-78. PMID 16572459 DOI: 10.1002/Cne.20934  0.32
2005 Falluel-Morel A, Vaudry D, Aubert N, Galas L, Bernard M, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzales BJ. [Effects of PACAP and C2-ceramide on motility of cerebellar granule neurons: the fastest is not the farthest]. MéDecine Sciences : M/S. 21: 696-8. PMID 16115451 DOI: 10.1051/Medsci/2005218-9696  0.32
2005 Bourgault S, Létourneau M, Fournier A. Development and pharmacological characterization of "caged" urotensin II analogs. Peptides. 26: 1475-80. PMID 16042988 DOI: 10.1016/J.Peptides.2005.03.019  0.32
2005 Langlois C, Létourneau M, Turcotte K, Detheux M, Fournier A. PTHrP fragments 1-16 and 1-23 do not bind to either the ETA or the ETB endothelin receptors Peptides. 26: 1436-1440. PMID 16042983 DOI: 10.1016/J.Peptides.2005.03.017  0.32
2005 Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides. 26: 1394-400. PMID 16042979 DOI: 10.1016/J.Peptides.2005.03.029  0.32
2005 Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, De Léan A. Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model. Biochemistry. 44: 2397-408. PMID 15709752 DOI: 10.1021/Bi048251Y  0.32
2005 Falluel-Morel A, Vaudry D, Aubert N, Galas L, Benard M, Basille M, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ. Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proceedings of the National Academy of Sciences of the United States of America. 102: 2637-42. PMID 15695581 DOI: 10.1073/Pnas.0409681102  0.32
2005 Migneault A, Sauvageau S, Villeneuve L, Thorin E, Fournier A, Leblanc N, Dupuis J. Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide. American Journal of Respiratory and Critical Care Medicine. 171: 506-13. PMID 15579730 DOI: 10.1164/Rccm.200403-340Oc  0.32
2003 Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, Quirion R. Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. British Journal of Pharmacology. 139: 695-704. PMID 12812992 DOI: 10.1038/Sj.Bjp.0705306  0.32
2003 Brkovic A, Hattenberger A, Kostenis E, Klabunde T, Flohr S, Kurz M, Bourgault S, Fournier A. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. The Journal of Pharmacology and Experimental Therapeutics. 306: 1200-9. PMID 12807997 DOI: 10.1124/Jpet.103.052415  0.32
2003 Langlois C, Létourneau M, Lampron P, St-Hilaire V, Fournier A. Development of agonists of endothelin-1 exhibiting selectivity towards ET A receptors British Journal of Pharmacology. 139: 616-622. PMID 12788821 DOI: 10.1038/Sj.Bjp.0705252  0.32
2003 Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, Prigent A, Robinson JC, Pradier L, Ruberg M, Mirande M, Hirsch E, Rooney T, Fournier A, Brice A. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Human Molecular Genetics. 12: 1427-37. PMID 12783850 DOI: 10.1093/Hmg/Ddg159  0.32
2003 Grumolato L, Elkahloun AG, Ghzili H, Alexandre D, Coulouarn C, Yon L, Salier JP, Eiden LE, Fournier A, Vaudry H, Anouar Y. Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology. 144: 2368-79. PMID 12746297 DOI: 10.1210/En.2002-0106  0.32
2003 Grumolato L, Louiset E, Alexandre D, Aït-Ali D, Turquier V, Fournier A, Fasolo A, Vaudry H, Anouar Y. PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. The European Journal of Neuroscience. 17: 71-82. PMID 12534970 DOI: 10.1046/J.1460-9568.2003.02426.X  0.32
2002 Turquier V, Yon L, Grumolato L, Alexandre D, Fournier A, Vaudry H, Anouar Y. Pituitary adenylate cyclase--activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells. Annals of the New York Academy of Sciences. 971: 471-3. PMID 12438167 DOI: 10.1111/J.1749-6632.2002.Tb04511.X  0.32
2002 Grumolato L, Alexandre D, Turquier V, Ait-Ali D, Fournier A, Vaudry H, Anouar Y. Pituitary adenylate cyclase-activating polypeptide regulates neuroendocrine markers and transcription factors in differentiating pheochromocytoma cells. Annals of the New York Academy of Sciences. 971: 467-70. PMID 12438166 DOI: 10.1111/J.1749-6632.2002.Tb04510.X  0.32
2002 Vaudry D, Pamantung TF, Basille M, Rousselle C, Fournier A, Vaudry H, Beauvillain JC, Gonzalez BJ. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. The European Journal of Neuroscience. 15: 1451-60. PMID 12028355 DOI: 10.1046/J.1460-9568.2002.01981.X  0.32
2001 Turquier V, Yon L, Grumolato L, Alexandre D, Fournier A, Vaudry H, Anouar Y. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors. Molecular Pharmacology. 60: 42-52. PMID 11408599 DOI: 10.1124/Mol.60.1.42  0.32
2000 Breault L, Yon L, Montéro M, Chouinard L, Contesse V, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N. Occurrence and effect of PACAP in the human fetal adrenal gland Annals of the New York Academy of Sciences. 921: 429-433. PMID 11193870 DOI: 10.1111/J.1749-6632.2000.Tb07010.X  0.32
2000 Alexandre D, Anouar Y, Jégou S, Fournier A, Vaudry H. Molecular cloning, mRNA distribution and pharmacological characterization of a VIP/PACAP receptor in the frog Rana ridibunda. Annals of the New York Academy of Sciences. 921: 300-3. PMID 11193839 DOI: 10.1111/J.1749-6632.2000.Tb06981.X  0.32
1999 Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Endocrinology. 140: 1285-93. PMID 10067855 DOI: 10.1210/Endo.140.3.6576  0.32
1998 Breault L, Yon L, Montéro M, Contesse V, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N. Presence of PACAP and PACAP receptors in the human adrenal gland: Possible role in fetal development Endocrine Research. 24: 961-962. PMID 9888606 DOI: 10.3109/07435809809032716  0.32
1998 Remy-Jouet I, Cartier F, Lesouhaitier O, Kuhn JM, Fournier A, Vaudry H, Delarue C. Mechanism of action of endothelins on adrenocortical cells. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 30: 341-5. PMID 9694560 DOI: 10.1055/s-2007-978895  0.32
1997 Jacques D, Dumont Y, Fournier A, Quirion R. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience. 79: 129-48. PMID 9178870 DOI: 10.1016/S0306-4522(96)00639-2  0.32
1996 Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: Exclusive role of ET(B) receptors Journal of Applied Physiology. 81: 1510-1515. PMID 8904561 DOI: 10.1152/Jappl.1996.81.4.1510  0.32
1995 Lesouhaitier O, Esneu M, Kodjo MK, Hamel C, Contesse V, Yon L, Remy-Jouet I, Fasolo A, Fournier A, Vandesande F, Pelletier G, Conlon JM, Roubos EW, Feuilloley M, Delarue C, et al. Neuroendocrine communication in the frog adrenal gland Zoological Science. 12: 255-264. PMID 7580809 DOI: 10.2108/Zsj.12.255  0.32
1992 Drumheller A, Menard D, Fournier A, Jolicoeur FB. Neurochemical effects of CGRP Annals of the New York Academy of Sciences. 657: 546-548. PMID 1637121 DOI: 10.1111/J.1749-6632.1992.Tb22830.X  0.32
1992 Jolicoeur FB, Menard D, Fournier A, St-Pierre S. Structure-activity analysis of CGRP's neurobehavioral effects Annals of the New York Academy of Sciences. 657: 155-163. PMID 1637081 DOI: 10.1111/J.1749-6632.1992.Tb22764.X  0.32
1992 Kalra SP, Fuentes M, Fournier A, Parker SL, Crowley WR. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology. 130: 3323-30. PMID 1317781 DOI: 10.1210/Endo.130.6.1317781  0.32
1991 Jolicoeur FB, Michaud JN, Menard D, Fournier A. In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors Brain Research Bulletin. 26: 309-311. PMID 2012991 DOI: 10.1016/0361-9230(91)90243-D  0.32
1991 Kalra SP, Dube MG, Fournier A, Kalra PS. Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists Physiology and Behavior. 50: 5-9. PMID 1658831 DOI: 10.1016/0031-9384(91)90490-F  0.32
1988 Fournier A, Saunders JK, Boulanger Y, St-Pierre SA. Conformational analysis of vasoactive intestinal peptide and related fragments Annals of the New York Academy of Sciences. 527: 51-57. PMID 3389647 DOI: 10.1111/J.1749-6632.1988.Tb26972.X  0.32
Show low-probability matches.